Table 3.
Patient's characteristics according to the lymphadenectomy or radiotherapy treatment.
|
N (%) |
||||
|---|---|---|---|---|
| Lymphadenectomy |
Radiotherapy |
|||
| No | Yes | No | Yes | |
| Median age (years) | 66.4 | 61.4 | 63.9 | 64 |
| FIGO stage | ||||
| I | 79 (66.4%) | 96 (67.6%) | 85 (85.9%) | 90 (55.6%) |
| II | 25 (21%) | 22 (15.5%) | 8 (8%) | 39 (24%) |
| III | 15 (12.5%) | 24 (16.9%) | 6 (5%) | 33 (20.4%) |
| Histological type | ||||
| Adenocarcinoma | 78 (65.6%) | 117 (82.4%) | 70 (70.7%) | 125 (77.2%) |
| Papillary – serous | 10 (8.4%) | 9 (6.3%) | 9 (9%) | 10 (6.2%) |
| Clear-cell | 4 (3.4%) | 6 (4.2%) | 10 (10.1%) | 17 (10.5%) |
| Other | 27 (22.7%) | 10 (7%) | 10 (10.1%) | 10 (6.2%) |
| Pathological grade | ||||
| I | 49 (41.2%) | 55 (38.7%) | 44 (44.4%) | 60 (37%) |
| II | 55 (46.2%) | 53 (37.3%) | 45 (45.6%) | 63 (38.9%) |
| III | 15 (12.6%) | 34 (23.9%) | 10 (10%) | 39 (24%) |
| Myometrial invasion | ||||
| No invasion | 11 (9.2%) | 10 (7%) | 9 (9%) | 12 (7.4%) |
| >50% | 62 (52.1%) | 50 (35.2%) | 60 (60.6%) | 52 (32%) |
| <50% | 46 (38.7%) | 82 (57.7%) | 30 (30.3%) | 98 (60.5%) |